Wave Life Sciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell WVE and other ETFs, options, and stocks.

About WVE

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. 

CEO
Paul B. Bolno
CEOPaul B. Bolno
Employees
288
Employees288
Headquarters
Singapore, Central Singapore
HeadquartersSingapore, Central Singapore
Founded
2012
Founded2012
Employees
288
Employees288

WVE Key Statistics

Market cap
1.06B
Market cap1.06B
Price-Earnings ratio
-7.54
Price-Earnings ratio-7.54
Dividend yield
Dividend yield
Average volume
1.74M
Average volume1.74M
High today
$6.95
High today$6.95
Low today
$6.58
Low today$6.58
Open price
$6.65
Open price$6.65
Volume
1.74M
Volume1.74M
52 Week high
$16.74
52 Week high$16.74
52 Week low
$5.28
52 Week low$5.28

WVE News

TipRanks 13h
Wave Life Sciences Highlights WVE-007 Obesity Treatment

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

TipRanks 1d
Invivyd appoints Wave Life Sciences CEO Paul Bolno to board

Invivyd (IVVD) announced the appointment of Paul Bolno to its board of directors and as a member of the compensation committee. Bolno is the president and CEO o...

Analyst ratings

93%

of 15 ratings
Buy
93.3%
Hold
6.7%
Sell
0%

People also own

Based on the portfolios of people who own WVE. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.